| CPC A61L 31/10 (2013.01) [A61L 17/145 (2013.01); A61L 27/34 (2013.01); A61L 27/56 (2013.01); A61L 31/146 (2013.01); A61L 2400/16 (2013.01); A61L 2430/36 (2013.01)] | 17 Claims |

|
1. A system comprising:
a substrate of a medical device;
an un-foamed, hydrophilic, aliphatic coating on the substrate and fixedly attached to the substrate;
a thermoset polyurethane shape memory polymer (SMP) foam, having a primary state and a programmed secondary state, which directly contacts the coating and fixedly attaches to the coating;
wherein:
the coating fixedly attaches the SMP foam to the substrate;
the SMP foam is in the primary state;
the SMP foam has first and second portions that each include cells the first portion being directly between the second portion and the coating;
the SMP foam includes a reaction product of triethanolamine (TEA) and hexamethylene diisocyanate (HDI); the cells of the first portion have a first average cell diameter; and the cells of the second portion have a second average cell diameter that is greater than the first average cell diameter.
|